Comprehensive Genomic Profiling for Hematologic Malignancies Using NGS Technology

The IVDNGS™ Blood Cancer Panel (Somatic & Germline) is an advanced, Next-Generation Sequencing (NGS)-based assay designed to detect clinically relevant genetic alterations associated with a broad spectrum of hematological malignancies. This dual-purpose panel allows for the identification of both somatic mutations (tumor-acquired) and germline variants (inherited), offering a complete genetic landscape for personalized diagnosis, prognosis, and therapy selection.

With high analytical sensitivity and coverage across a wide range of gene targets, this panel is ideal for leukemia, lymphoma, myeloma, and other blood cancers.